Both autologous and allogeneic transplants have been extensively studied in the management of non-Hodgkin's lymphomas and may offer a chance of a long-term cure for some patients. Autologous stem cell transplantation is considered standard therapy for patients with diffuse large B cell lymphoma in ...
High Dose Therapy (HDT) and Autologous hematopoietic stem-cell transplantation (ASCT) represents the best available treatment option for patients with primary refractory or relapsed Hodgkin's Lymphoma (HL). HDT and ASCT has also been used as part of the front-line treatment in patients with very...
doi:10.1080/10245332.2000.11746492BrunoGabrielaV.BallesterOscarF.Hematology
High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using un... High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non- Hodgkin's lym...
Hematopoietic stem cell transplantation (HSCT) as salvage for non-hodgkin lymphoma (NHL) in children and adolescents: A report from the center for international blood and marrow transplant research (CIBMTR)T.G., GrossG.A., HaleW., He
Individuals who may take advantage of stem cell treatments consist of those with leukemia, Hodgkin illness, non-Hodgkin lymphoma and some strong growth cancers. Stem cell treatments likewise may benefit individuals who have aplastic anemia, immunodeficiencies and acquired conditions of metabolic process....
S Poppema,JD Elema,MR Halie - 《Cancer》 被引量: 421发表: 1981年 Paraneoplastic Pemphigus 's tumor, non-Hodgkin's lymphoma, thymoma, follicular dendritic cell sarcoma and chronic lymphocytic leukemia are the commonly associated neoplasmas in PNP... AM Poot,GFH Diercks,HH Pas,... - 《Journ...
The evaluation of allogeneic stem cell treatment is complicated by the fact that the various forms of the disease are rare. Even if all types of non-Hodgkin lymphoma are considered together, there are currently only about 250 patients per year in Germany who receive allogeneic stem cell transplan...
Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma 来自 clinicaltrialsfeeds.org 喜欢 0 阅读量: 9 作者: N University 年份: 2004 ...
After salvage chemotherapy and collection of peripheral stem cell progenitors (median CD34<sup>+</sup> cells/kg: 11 ´ 10<sup>6</sup>/kg), (n = 15) patients with aggressive non-Hodgkin's lymphoma with poor prognostic factors or refractory Hodgkin's disease (n= 9) received intensified ...